Schroder Investment Management Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.41M | Buy |
386,539
+94,744
| +32% | +$1.33M | ﹤0.01% | 754 |
|
|
2025
Q1 | $4.31M | Buy |
291,795
+43,995
| +18% | +$650K | ﹤0.01% | 782 |
|
|
2024
Q4 | $5.02M | Buy |
247,800
+120,494
| +95% | +$2.44M | ﹤0.01% | 768 |
|
|
2024
Q3 | $3.75M | Sell |
127,306
-218,067
| -63% | -$6.42M | ﹤0.01% | 844 |
|
|
2024
Q2 | $8.02M | Buy |
+345,373
| New | +$8.02M | 0.01% | 677 |
|
|
2024
Q1 | – | Sell |
-154,000
| Closed | -$3.3M | – | 1207 |
|
|
2023
Q4 | $3.3M | Buy |
+154,000
| New | +$3.3M | ﹤0.01% | 837 |
|